![[LSF] Life-Sciences-France.com - The French Life Sciences Web Portal](/images/basics/lsf-life-sciences-france-portal-logo.svg){kind=logo}
Advertisement
Persons > All
France
Monaco
Central France
Eastern France
Northern France
Paris (region)
Southern France
Western France
Find below all kinds of persons from France & Monaco.Total search results: 2420 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Del, Jean-Philippe (Transgene 202202 CFO) | Chief Financial Officer (CFO) | Mérieux (Group) | Grand Est (Great East) (region) |
| Delansorne, Rémi (Hybrigenics 201110 CEO) | Chief Executive Officer (CEO) | Hybrigenics (Group) | Île-de-France (region) |
| Delassus, Sylvie (Cellectis 201105 SVP Corporate Communication) | Public Relations Manager / Investor Relations Manager | Cellectis (Group) | Île-de-France (region) |
| Delbrut, Antoine (Microphyt 201805– Product Manager) | Product Manager (personnel) | Microphyt S.A. | Occitanie (Occitania) (region) |
| Delcourt, Marc (Global Bioenergies 201311 CEO) | Chief Executive Officer (CEO) | Global Bioenergies (Group) | Île-de-France (region) |
| Deleage, Jean (Alta Partners 200610 Managing Partner) | Managing Partner (investment firm) | Alta Partners | California (federal state) |
| Delenda, Christophe (Cellectis 201107 CSO of Cellectis Bioresearch) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Cellectis (Group) | Île-de-France (region) |
| Delepierre, Muriel (Institut Pasteur 201703 Professor) | Professor | Institut Pasteur | Île-de-France (region) |
| Delouvrier, Louis-Victor (NewCap 201809) | Public Relations Manager / Investor Relations Manager | NewCap. – Investor Relations & Financial Communications | Île-de-France (region) |
| Delval, Ingrid (Aqemia 202312 Chief of Staff to CEO) | n. a. | Aqemia SAS | Île-de-France (region) |
| Demiddeleer, Leopold (EnobraQ 201511– President) | Chief Executive Officer (CEO) | EnobraQ (FR) | Occitanie (Occitania) (region) |
| Denis, Florian (Elaia Partners 202104 Investment Director) | Investment Manager | Elaia Partners (Group) | Île-de-France (region) |
| Dennery, Xavier (Eurofins 200704– CEO Environment testing business has been 2y before w Eurofins) | Chief Executive Officer (CEO) | Eurofins (Group) | Pays de la Loire (region) |
| Depil, Stéphane (Servier 201112 Head Oncology Research & Development) | Research & Development Manager | Servier (Group) | Île-de-France (region) |
| Derveloy, Audrey (Sanofi 202405 President of Sanofi France) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Descargues, Pascal (Genoskin 201708 CEO + Founder) | Chief Executive Officer (CEO) | Genoskin (Group) | Occitanie (Occitania) (region) |
| Deschner, Alexandra (Consilium 202303– Senior Strategic Advisor before Univercells + Mithra Pharma + UCB + Fiat) | Public Relations Manager / Investor Relations Manager | ICR (Group) | Greater London (region) |
| Desdouits, Frédéric (TreeFrog Therapeutics 202109– CEO before PCAS + Seqens + Pierre Fabre + Bionest Partners) | Chief Executive Officer (CEO) | TreeFrog Therapeutics (Group) | Nouvelle-Acquitaine (New Acquitaine) (region) |
| Dessertenne, Eric (Biocorp (FR) 201507 Head Commercial Operations + Business Development) | Business Development Manager / Strategy Manager | Biocorp (Alternext: ALCOR) | Auvergne-Rhône-Alpes (region) |
| Detheux, Michel (iTeos Therapeutics 201205 CEO + Co-founder) | Chief Executive Officer (CEO) | iTeos Therapeutics (Group) | Wallonia (region) |
| DeWitt, Ann (MIT 202102 General Partner at The Engine formerly Sanofi-Genzyme BioVentures + Permeon Biologics) | Investment Manager | MIT (Massachusetts Institute of Technology) | Massachusetts (federal state) |
| Dhellin, Olivier (Neovacs 201607– CEO of joint venture Neostell SAS before Anosys) | Chief Executive Officer (CEO) | Neovacs (Group) | Île-de-France (region) |
| Dhingra, Kapil (independent consultant + board member since 2008 before Roche + Eli Lilly) | Board member, non-executive | Mariana Oncology Inc. | Massachusetts (federal state) |
| Dhingra, Kuldeep (Spectro Analytical Labs (IN) 201711 Managing Director) | Managing Director | Eurofins (Group) | Delhi (National Capital Territory of Delhi) |
| Di Giorgio, Roberta (DBV Technologies 201709 Head Corp Communications) | public relations / investor relations | DBV Technologies S.A. (Euronext Paris: DBV + Nasdaq Global Select Market: DBVT) | Île-de-France (region) |
| Diaz, Allene M. (Tesaro 201609 SVP Global Commerical Developm before Merck Serono + Biogen Idec + Pfizer) | Chief Commercial Officer (CCO) | GSK (Group) | Massachusetts (federal state) |
| Dible, David (Huntsworth 201506 Senior Director Life Sciences at Citigate Dewe Rogerson London) | Public Relations Manager / Investor Relations Manager | Inizio (Group) | Greater London (region) |
| Dieye, Mame (France (govt) 202001 Regional Director at Bpifrance Poitiers) | n. a. | France (govt) | Île-de-France (region) |
| Dilly, Stephen (Sierra Oncology 202204 CEO formerly Aimmune Therapeutics 201611–201806 CEO + Chiron BioPharma) | Chief Executive Officer (CEO) | GSK (Group) | California (federal state) |
| Dimitropoulos, Chris (Alpha Wave Global 202401 Managing Director of Healthcare Investments) | Managing Partner (investment firm) | Alpha Wave Global (Group) | New York (federal state) |
| Dinard, Delphine (ACE Management 201801 Investment Director) | Investment Manager | ACE Management SA à directoire et conseil de surveillance | Île-de-France (region) |
| Ding, Richard (bioMérieux 200809 VP BusDev + Theranostics also bioTheranostics 200809– CEO) | Chief Executive Officer (CEO) | Hologic (Group) | California (federal state) |
| Dinges, Jason (Morningside 201602 Investment Manager) | Investment Manager | Morningside (Chan family of Hong Kong) (Group) | Massachusetts (federal state) |
| Dirkes-Kersting, Astrid (Hygel 201705 Managing Director) | Managing Director | Eurofins (Group) | Nordrhein-Westfalen (federal state) |
| Dixon, Graham (Onxeo 2015– CSO before Sensorion + Addex + Galapagos + Entomed + F2G + AstraZeneca) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Onxeo (Group) | Île-de-France (region) |
| Djokovic, Noémie (Sensorion 202402 Investor Relations + Communications Associate) | Public Relations Manager / Investor Relations Manager | Sensorion S.A. (Euronext Alternext: ALSEN) | Occitanie (Occitania) (region) |
| Do, Hervé (Peptinov 201508 VP Business Development joined 2009) | Business Development Manager / Strategy Manager | Peptinov SAS | Île-de-France (region) |
| Dobbs, Felix (Broken String Biosciences 202309 CEO) | Chief Executive Officer (CEO) | Broken String Biosciences Ltd. | East of England (region) |
| Dochez, Luc (Vico Therapeutics 202007 CEO + Co-Founder + Droia Genetic Disease Fund Managing Partner before Prosensa) | Chief Business Officer (CBO) | Vico Therapeutics B.V. | South Holland (province, NL) |
| Dodet, Julien (Orano 202309 CEO of Orano Med) | Chief Executive Officer (CEO) | Orano (Group) | Île-de-France (region) |
| Dodion, Pierre (Alacrita 201401– Associate Partner before Ariad + Aventis + Novartis + Pfizer) | Consultant (economic/technology) | Alacrita (Group) | Massachusetts (federal state) |
| Dodion, Pierre (Innate Pharma 201909 CMO) | Chief Medical Officer (CMO) | Innate Pharma S.A. (Euronext Paris: IPH, Nasdaq: IPHA) | Provence-Alpes-Côte d’Azur (region) |
| Dohrmann, Cord (Evotec 201009– CSO before 10y at DeveloGen incl CSO + CEO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Evotec (Group) | Niedersachsen (federal state) |
| Doize, Nathalie (Excelya 202103– Director of Operations before Syneos Health + Mapi Group + inVenti Health Clinical) | Chief Operating Officer (COO) | Excelya (Group) | Île-de-France (region) |
| Doligez, Claire (Image Sept 201405 Consultant) | Public Relations Manager / Investor Relations Manager | Image Sept (FR) | Île-de-France (region) |
| Doliveux, Roch (UCB 200602 CEO) | Chief Executive Officer (CEO) | UCB (Group) | Brussels (region) |
| Dolsten, Mikael (Pfizer 201005– President ww R&D before Wyeth 200901 President Wyeth Research before Boehringer) | Research & Development Manager | Pfizer (Group) | New York (federal state) |
| Dominguez, Virginie (Servier 202010– Chief Digital Officer before Orange Group since 2003) | Chief Information Officer (CIO) / Chief Digital Officer | Servier (Group) | Île-de-France (region) |
| Donadio, Stefano (Naicons Srl 201804 CEO before Biosearch Italia + Lepetit + Abbot Labs) | Chief Executive Officer (CEO) | Naicons S.r.l. | Italy_o |
| Dong, Jianhua (Hybiome (CN) 2009– Founder + Chairman) | Board member | Mérieux (Group) | Jiangsu (Kiangsu) (province) |
| Donlan, Mary E. (Aureus Pharma 200504) | n. a. | Reed Elsevier (Group) | Île-de-France (region) |
| Donne, Nathalie (ErVaccine 202301 CEO fomerly DBV Technologies 201507) | Public Relations Manager / Investor Relations Manager | ErVaccine Technologies S.A. | Auvergne-Rhône-Alpes (region) |
| Dormann, Jürgen | Chief Executive Officer (CEO) | Sanofi (Group) [since May 2011] | Hessen (Hesse) (federal state) |
| Dormes, Elodie (General Inception 202404 Communciations) | public relations / investor relations | General Inception (Group) | California (federal state) |
| Dostie, Alain (Nanobiotix 2017– COO) | Chief Operating Officer (COO) | Nanobiotix (Group) | Île-de-France (region) |
| Douat, Christophe (MedinCell 201810 Board Chairman) | Board member | MedinCell (Group) | Occitanie (Occitania) (region) |
| Dougherty, Joseph (Anormed 200610) | n. a. | Sanofi (Group) [since May 2011] | British Columbia |
| Douglas, James (Exonhit– VP 200801 Corp Developm before Epigenomics 200601–200712 before Biosite) | Business Development Manager / Strategy Manager | Eurobio Scientific (Group) | Île-de-France (region) |
| Doyle, Anthony (BioCryst 202004– CFO before Wordwide Clinical Trials + GE Healthcare + World Book) | Chief Financial Officer (CFO) | BioCryst Pharmaceuticals Inc. (Nasdaq: BCRX) | North Carolina (federal state) |
| Doyle, Stephen (Aslan Pharmaceuticals 202103 CBO before Boehringer Ingelheim + Sanofi) | Chief Business Officer (CBO) | Aslan Pharmaceuticals Ltd. (Nasdaq: ASLN) | Singapore (cl=4) |
| Drago, Stefano (PAI Partners 202312 Partner) | Partner (venture partner) | PAI Partners (Group) | Île-de-France (region) |
| Droguet, Benjamin (Sparxell 202209– CEO + Co-Founder) | Chief Executive Officer (CEO) | Sparxell UK Ltd. | East of England (region) |
| Droller, Rémi (Kurma 201305 Managing Partner at Kurma Life Sciences Partners) | Managing Partner (investment firm) | Eurazeo (Group) | Île-de-France (region) |
| Drucker, Miron (MegaPharm 201106 CEO + founder before Managing Director of Israel sub of Hoechst AG) | Chief Executive Officer (CEO) | MegaPharm Ltd. | Israel_o |
| Drumm, Joshua (Valneva 202108 VP Global Investor Relations before AC Immune) | Public Relations Manager / Investor Relations Manager | Valneva (Group) | Pays de la Loire (region) |
| du Peloux, Alexis (Siparex 202203 Principal at XAnge) | Principal (venture capital) | Siparex (Group) | Île-de-France (region) |
| Du, Bo (Genecast (CN) 201904 CEO + Founder) | Chief Executive Officer (CEO) | Genecast (CN) | China_o |
| Dubois, Michel (bioMérieux 200607– Chairman) | n. a. | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Dubos, Sandra (France (govt) 201802 Business Innovation Manager at Bpifrance) | n. a. | France (govt) | Île-de-France (region) |
| Dubosq, Stephan (201411 FTI Consulting Paris) | Public Relations Manager / Investor Relations Manager | FTI Consulting (Group) | Île-de-France (region) |
| Dubruque, Matthieu (OCR (FR) 201901 CBO) | Chief Business Officer (CBO) | OCR (Oncovet Clinical Research) (FR) | Hauts-de-France (Upper France) (region) |
| Dubruque, Samuel (Global Bioenergies 201710– CFO joined 2013 before Suez + Total) | Chief Financial Officer (CFO) | Global Bioenergies (Group) | Île-de-France (region) |
| Duchateau, Philippe (Cellectis 201802 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Cellectis (Group) | Île-de-France (region) |
| Duchesne de Lamotte, Hervé (ExonHit 200911– CFO before Cirrus Finance Management before IDM Paris) | Chief Financial Officer (CFO) | Eurobio Scientific (Group) | Île-de-France (region) |
| Duchesne, Frédéric (Pierre Fabre 201404 President of Pierre Fabre Pharmaceuticals) | President/Director/Head Business Group/Unit/Division | Pierre Fabre (Group) | France (region/state unspecified) |
| Duchiron, Camille (Taddeo 202309) | Public Relations Manager / Investor Relations Manager | Taddeo SAS | Île-de-France (region) |
| Ducournau, Eric (Pierre Fabre 201807– CEO before CEO of Pierre Fabre Dermo-Cosmetics joined 2000) | Chief Executive Officer (CEO) | Pierre Fabre (Group) | Île-de-France (region) |
| Dufour, Sandrine (UCB 202007– CFO before Proximus + Vivendi + SFR) | Chief Financial Officer (CFO) | UCB (Group) | Brussels (region) |
| Dufour-Lamartinie, Jean-François (Hybrigenics 201111 Head Clinical RnD) | Research & Development Manager | Hybrigenics (Group) | Île-de-France (region) |
| Dufresne, Pierre (SATT Toulouse Tech Transfer 201803 President) | President/Director/Head Business Group/Unit/Division | SATT Toulouse Tech Transfer | Occitanie (Occitania) (region) |
| Dugray, Americ (Antabio 201604 CFO) | Chief Financial Officer (CFO) | Antabio SAS | Occitanie (Occitania) (region) |
| Dujardin, Philippe (Lys Therapeutics 202208 CFO + Co-Founder) | Chief Financial Officer (CFO) | Lys Therapeutics SAS | Auvergne-Rhône-Alpes (region) |
| Dumoussaud, Christelle (Enterome 2015– CFO) | Chief Financial Officer (CFO) | Enterome S.A. | Île-de-France (region) |
| Dupont-Inglis, Joanna (EuropaBio 201809– Secretary General) | lobbying | EuropaBio aisbl – the European Association of Bioindustries | Brussels (region) |
| Dupont-Sentilles, Thomas (Goodwin Procter 202104 Partner at Paris Office) | Attorney / Lawyer | Goodwin Procter (Goowin Law) (Group) | Île-de-France (region) |
| Duportet, Xavier (Eligo Bioscience 201405– CEO + Co-Founder) | Chief Executive Officer (CEO) | Eligo Bioscience S.A. | Île-de-France (region) |
| Durand-Salmon, Frédéric (Alira Health 202110– VP Clinical Digital Solutions before CEO + Founder of Bepatient) | President/Director/Head Business Group/Unit/Division | Alira Health (CMC Consulting Boston) (Group) | Île-de-France (region) |
| Durano, Jean-Marc (Meriéux 201106 Corporate VP Industrial Microbiology at bioMérieux) | President/Director/Head Business Group/Unit/Division | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Durant des Aulnois, Stéphane (Corteria Pharmaceuticals 202301– before Lysogene + Ipsen + LaSalle Investment) | Chief Financial Officer (CFO) | Lysogene S.A. (Euronext Paris: LYS) | Île-de-France (region) |
| Durrèche, Magalie (CorWave 202304– CFO before Stellantis + PSA + Sodexo + PwC) | Chief Financial Officer (CFO) | CorWave S.A. | Île-de-France (region) |
| Dusek, Alex (Erytech 201805– VP Commercial Strategy before Argos Therapeutics + Bayer HealthCare + United Therapeutics) | Business Development Manager / Strategy Manager | Erytech (Group) | Massachusetts (federal state) |
| Dutang, Eric (Cellectis 2016– CFO joined 201505) | Chief Financial Officer (CFO) | Cellectis (Group) | Île-de-France (region) |
| Duvaux, Odile (Xenothera 202106 President + Founder) | President/Director/Head Business Group/Unit/Division | Xenothera (FR) | Pays de la Loire (region) |
| Dwyer, Michael T. (Azaya 200506– CEO before i3 Research before Ilex Oncology) | Chief Executive Officer (CEO) | Azaya Therapeutics Inc. | Texas (federal state) |
| Dwyer, Wendy (Surface Oncology 201904– CBO before Portal Instruments + AstraZeneca + Ipsen Biosciences + Endo + Indevus) | Chief Business Officer (CBO) | Surface Oncology Inc. | Massachusetts (federal state) |
| Dyer, Anthony (Novacyt 201409– Finance Director before part time Group Financial Controller) | Chief Financial Officer (CFO) | Novacyt (Group) | Île-de-France (region) |
| Dyer, Tim (Addex CEO 201802 formerly CFO + Co-Founder) | Chief Executive Officer (CEO) | Addex (Group) | Région Lémanique (region) |
| d’Arbonneau, Pascale (Carmat 201812– CFO before Econocom International + GSK 1999–2016) | Chief Financial Officer (CFO) | Carmat S.A. (ALCAR) | Île-de-France (region) |
| D’Cruz, Cony (Proteros 201008– CBO + President Proteros US Inc before Evotec SVP North America) | Chief Business Officer (CBO) | Proteros (Group) | Massachusetts (federal state) |
| d’Epenoux, Pierre (ImCheck Therapeutics 201705– CEO) | Chief Executive Officer (CEO) | ImCheck Therapeutics SAS | Provence-Alpes-Côte d’Azur (region) |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
